ArticleBMC cancer2023

Ray of dawn: Anti-PD-1 immunotherapy enhances the chimeric antigen receptor T-cell therapy in Lymphoma patients.

Yuxin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.